期刊文献+

辛伐他汀治疗高脂血症的疗效和安全性临床观察 被引量:6

下载PDF
导出
摘要 目的探讨辛伐他汀治疗高脂血症患者的疗效和安全性。方法入选高脂血症患者96例,给予辛伐他汀20 mg,每日1次,于晚睡前口服。观察患者在治疗前、治疗后3个月、6个月的血脂、肝肾功能、肌酸激酶,同时观察患者有无消化道症状、肌病、皮疹等不良反应。结果治疗3月、6月后TC、LDL-C均较治疗前显著下降(P<0.01),TG较治疗前明显降低(P<0.05),HDL-C较治疗前明显提高(P<0.05);TC、TG、LD-L-C、HDL-C治疗3月的总有效率分别为79.17%、60.61%、78.33%、34.09%,治疗6月的总有效率分别为83.33%、66.67%、85.00%、45.45%。结论辛伐他汀对高脂血症患者的调脂有肯定的疗效,同时是安全的,无明显肝肾功能损害,肌溶解等不良反应。
出处 《右江医学》 2007年第4期373-374,共2页 Chinese Youjiang Medical Journal
  • 相关文献

参考文献7

  • 1方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 2The Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4s)[J].Lancet,1994,344:1383-1389. 被引量:1
  • 3CRISBY M,NORDIN FG,SHAH PK,et al.Pravastatin treatment increases collagen contert and decreases and cell death in human carotid plaques:implications for plaque stabilization[J].Circulation,2001,103:926-933. 被引量:1
  • 4吕家高,陆再英.他汀类药物与冠心病[J].医药导报,2001,20(3):168-169. 被引量:27
  • 5李潞,刘虹,王宇,孙晓.阿托伐他汀在急性冠脉综合征早期应用的有效性研究[J].中国实用内科杂志,2003,23(4):219-220. 被引量:33
  • 6MAAS investigators.Effect of simvastatin on coronaru atheroma:the Multicenter Anti-Atheroma Study (MAAS)[J].Lancet,1994,344(8923):633-638. 被引量:1
  • 7Chinese Society of Cardiology,Chinese Medical Association,Editorial Broard of Chinese Joumal of Cardiology.Summary of the Second National Symposium on Dyslipidemia[J].China J Cardiol,2002,30(11):643-646. 被引量:1

二级参考文献8

  • 1[1]The Scandinavian Simvastatin Survival Group.Randomized trial of chole-sterol lowering in 4 444 patients with coronary heart disease:The Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344:1383-1389. 被引量:1
  • 2[2]Shepherd J,Cobbe S M,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N Engl J med,1995,333(20):1301-1307. 被引量:1
  • 3[3]Jukema J W,Onbehalf to the REGRESS study group,InterUniversity Cardiology.Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels.The Regression Growth Evaluation Statin Study (REGRESS)[J].Circulation,1995,91:2528. 被引量:1
  • 4[4]Aikawa M,Rabkin E,Voglic S J,et al.Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma:a potential mechanism of lesion stabilization[J].Circulation,1998,95:2433-2444. 被引量:1
  • 5[5]MAAS Investigators.Effects of simvastatin on coronary atheroma:the multicentre anti-atheroma study (MAAS)[J].Lancet,1994,344:633. 被引量:1
  • 6[6]Crouse J R.Pravastatin,Lipids and atherosclerosis in the carotid arteries (PLAC-Ⅱ)[J].Am J Cardiol,1995,75:455-459. 被引量:1
  • 7[2]Jocelyn D, Jean CT, Prter C,et al. Cholesterol reduction rapidby improves endothelial function after acute coronary syndromes. Circulation,1999,99:3227-3233 被引量:1
  • 8[3]F.R. den Hartog, F.W.A. Verheugt.Early HMG-COA reductase inhibition in acute coronary syndromes:preliminary data of the pravastatin in acute ischaemic syndromes(PAIS)study.Eur Heart J,1998,19:2802 被引量:1

共引文献3109

同被引文献57

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部